Literature DB >> 19548178

Comparison of platelet aggregation using light transmission and multiple electrode aggregometry in Glanzmann thrombasthenia.

Abdalla Awidi1, Ahmad Maqablah, Manar Dweik, Nazzal Bsoul, Ahmad Abu-Khader.   

Abstract

We examined platelet aggregation in platelet-rich plasma (PRP) and in whole blood in nine patients with Thrombasthenia Glanzmann (TG). In PRP, aggregation was measured by monitoring the changes in light absorbance that occurred in response to adenosine 5-diphosphate (ADP), collagen and ristocetin. To measure platelet aggregation in whole blood, we used multiple electrode Impedance aggregometry using the same aggregating agents. In PRP, the patient's platelets showed defective aggregation in response to ADP, collagen, epinephrine and partially to ristocetin in all patients. In whole blood, platelet aggregation in response to the same aggregating agents showed similar response and appeared to be very similar to that which occurred in PRP. Whole blood impedance aggregometry seems to give similar results to PRP light transmission aggregometry in patients with TG. Multiple electrode aggregometry (MEA) is faster and more convenient to use in these patients.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19548178     DOI: 10.1080/09537100903006246

Source DB:  PubMed          Journal:  Platelets        ISSN: 0953-7104            Impact factor:   3.862


  3 in total

1.  Gender difference in platelet aggregation and reactivity induced by recombinant human erythropoietin.

Authors:  Lucrezia Gambardella; Rosa Vona; Simona Pichini; Roberta Pacifici; Walter Malorni; Elisabetta Straface
Journal:  Br J Clin Pharmacol       Date:  2016-02-01       Impact factor: 4.335

2.  The role of PGE(2) in human atherosclerotic plaque on platelet EP(3) and EP(4) receptor activation and platelet function in whole blood.

Authors:  Lisa J Schober; Anna L Khandoga; Suman Dwivedi; Sandra M Penz; Takayuki Maruyama; Richard Brandl; Wolfgang Siess
Journal:  J Thromb Thrombolysis       Date:  2011-08       Impact factor: 2.300

3.  Evaluation of hemostasis in patients with end-stage renal disease.

Authors:  Anja Gäckler; Hana Rohn; Ton Lisman; Tamas Benkö; Oliver Witzke; Andreas Kribben; Fuat H Saner
Journal:  PLoS One       Date:  2019-02-20       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.